abstract |
The present invention relates to a novel compound which inhibits Lp-PLA 2 activity, a process for its preparation, a composition containing it, and diseases associated with the activity of Lp-PLA 2 , such as atherosclerosis, Alzheimer's disease and / or diabetic macular edema ≪ / RTI > (I) |